1. Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT;
2. Department of Biostatistics, Yale School of Public Health, New Haven, CT;
3. Department of Medicine, University of Valencia, Hospital Universitario y Politécnico La Fe, Valencia, Spain;
4. Section of Hematology, Saint-Louis Hospital, University Paris 7, Paris, France;
5. Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY;
6. Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;
7. Massachusetts General Hospital Cancer Center, Department of Hematology/Oncology, Harvard Medical School, Boston, MA;
8. Department of Malignant Hematology, Moffitt Cancer Center and Research Institute, Tampa, FL;
9. Division of Oncology & Hematology, University of Nebraska Medical Center, Omaha, NE;
10. Division of Hematology, Mayo Clinic, Rochester, MN;
11. Cote d'Azur University, Nice Sophia Antipolis University, Centre Hospitalier Universitaire de Nice, Nice, France;
12. Division of Hematology, University of Florence, Azienda Ospedaliero Universitaria Careggi, Florence, Italy;
13. Department of Pharmacy, Yale New Haven Hospital, New Haven, CT;
14. Department of Hematology, Institut Paoli Calmettes, Marseille, France;
15. Department of Haematology, Oncology and Clinical Immunology, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany;
16. Section of Hematology, Hospital San Pedro Alcántara, Cáceres, Spain; and
17. Section of Hematology, University Hospital Reina Sofia, Cordoba, Spain